New hope for kids with severe eczema: drug trial shows promise
NCT ID NCT05388760
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 33 times
Summary
This study tested a drug called tralokinumab in 28 children aged 6 to 12 with moderate-to-severe eczema. The goal was to see how the drug moves through the body and if it is safe and effective. Children received injections over many weeks and used moisturizer daily. The drug aims to control the disease, not cure it, and ongoing treatment may be needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
LEO Pharma Investigational Site
Brno, 625 00, Czechia
-
LEO Pharma Investigational Site
Prague, 150 06, Czechia
-
LEO Pharma Investigational Site
Reims, Ardennes, 51100, France
-
LEO Pharma Investigational Site
Rotterdam, 3011 TG, Netherlands
-
LEO Pharma Investigational Site
Utrecht, 3584 CX, Netherlands
-
LEO Pharma Investigational Site
Cadiz, Andalusia, 11009, Spain
-
LEO Pharma Investigational Site
Esplugues de Llobregat, Barcelona, 08950, Spain
-
LEO Pharma Investigational Site
Alicante, 03010, Spain
-
LEO Pharma Investigational Site
Manchester, Greater Manchester, M13 9WL, United Kingdom
-
LEO Pharma Investigational Site
London, SE1 9RT, United Kingdom
-
LEO Pharma Investigational Site
Sheffield, S10 2TH, United Kingdom
Conditions
Explore the condition pages connected to this study.